Sustained-release dosage form of nicardipine hydrochloride: Application of factorial design and effect of surfactant on release kinetics

Drug Development and Industrial Pharmacy

Volumn 23, Issue 8, 1997, Pages 761-770

  Ozyazici M ^a   Sevgi, F ^a   Ertan, G ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXANE; ETHYL CELLULOSE; NICARDIPINE; POLYSORBATE 20; SURFACTANT;

ARTICLE; CONTROLLED STUDY; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG COATING; DRUG DOSAGE FORM; DRUG RELEASE; DRUG SOLUBILITY; FACTORIAL ANALYSIS; KINETICS; MATHEMATICAL MODEL; MICROCAPSULE; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SUSTAINED RELEASE PREPARATION; TECHNIQUE;

EID: 0030738372     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049709150547     Document Type: Article

References (61)

1. M. Guerret, G. Cheymol, M. Hubert, C. Julien-Larose, and D. Lavene, Eur. J. Clin. Pharmacol, 37, 381 (1989).
2. The Merck Index, 11th ed., Merck and Co. Inc., Rahway, 1989.
3. S.H. Baky, in "New Drugs Annual: Cardiovascular Drugs," A. Scriabine, eds., Roven Press, New York, 3, 1985, p. 153.
4. M. C. Bonferoni, G. Mellerio, P. Giunchedi, C. Caramella, and U. Conte, Int. J. Pharm., 80, 109 (1992).
5. D.J.M. Graham, R.J. Dow, D. Freedman, E. Mroszczok, and T. Ling, Posgrad. Med. J., 60 (Suppl 4), 7 (1984).
6. D. R. Abernethy and J. B. Schwartz, Clinical Pharmacokinetics, 15, 1 (1988).
7. E. M. Sorkin and S. P. Clissold, Drugs, 33, 296 (1987).
8. A. Cavatorta, F. Pucci, A. Ghirarduzzi, G. Orlandini, R. Bolognesi, C. Manca, and A. Borghetti, Current Therapeutic Research, 48, 298 (1990).
9. C. Kim and E. Lee, Int. J. Pharm., 79, 11 (1992).
10. A. Hasegawa, R. Kawamura, H. Nakagawa, and I. Sugimata, Chem. Pharm. Bull. 34, 2183 (1986).
11. I. Jalsenjak, C. F. Nicolaidou, and J. R. Nixon, J. Pharm. Pharmacol., 28, 912 (1976).
12. S. Bolton, in Pharmaceutical Statistics, Marcel Dekker, New York, 1990, 2nd. ed., p. 262.
13. S. Bolton, J. Pharm. Sci., 72, 362 (1983).
14. J. O. Waltersson, Acta Pharmaceutica Suecica, 23, 129 (1986).
15. S. Dinçer and S. Özdurmuş, J. Pharm. Sci., 66, 1070 (1977).
16. J. B. Schwartz, J. R. Flamholz, and R. H. Press, J. Pharm. Sci., 62, 1165 (1973).
17. A. Devay, P. Fekete, and I. Racz, J. Microencapsulation, 1, 299 (1984).
18. M. Farivar, S. H. Kaş, L. Öner, and A. A. Hincal, J. Microencapsulation, 10, 309 (1993).
19. F. Sevgi, M. Özyazici, and T. Güneri, J. Microencapsulation, 11, 439 (1994).
20. Y. Karasulu, G. Ertan, and T. Güneri, Pharmacy World and Science 18, 20 (1996).
21. E. Scheffler, "Einfuhrung in die Praxis der Statistichen Versuchsplanung," DDR: VEB Deutscher Verlag für Grundstaf industrie, Leipzig, 1974.
22. M. Gibaldi and S. Feldman, J. Pharm. Sci., 59, 579 (1970).
23. A. L. Thakkar and N. A. Hall, J. Pharm. Sci., 56, 1121 (1967).
24. P. Finholt and S. Solvang, J. Pharm. Sci., 57, 1322 (1968).
25. A. A. Ismail, M. W. Gouda, and M. M. Motawi, J. Pharm. Sci., 59, 220 (1970).
26. M. W. Gouda, A. A. Ismail, and M. M. Motawi, J. Pharm. Sci., 59, 1402 (1970).
27. S. Önay-Başaran, Bulletin of Hacettepe Faculty of Pharmacy, 2, 80 (1982).
28. D. Duchéne, A. Djiane, and F. Puisieux, Ann. Pharm. Fr., 28, 289 (1970).
29. W. G. Cohran, G. M. Cox, "Experimental Designs," John Wiley and Sons, New York, 1957.
30. The United States Pharmacopeia XXII (USP XXII), Twinbrook Parkway, Rockville, MD, 1990, p. 1788.
31. J. G. Wagner, J. Pharm. Sci., 58, 1253 (1969).
32. J. G. Wagner, M. PErnarowski, in Biopharmaceutics and Relevant Pharmacokinetics, Drug Intelligence Publications, Hamilton, Illinois, 1971, 1st. ed., p. 108.
33. A. M. R. Alvarez and M. A. H. Villafuerte, Eur. J. Pharm. Biopharm., 37, 147 (1991).
34. F. Langenbucher, Pharmazeutische Industrie, 38, 472 (1976).
35. F. Langenbucher, J. Pharm. Pharmacol., 24, 979 (1972).
36. T. Higuchi, J. Pharm. Sci., 52, 1145 (1963).
37. H. B. Hopfenberg, "Controlled Release Polymeric Formulations," Amer. Chem. Soc. Press, Washington, D.C., 1976.
38. İ. T. Aǧabeyoǧlu, Un Programme Dans la Langue Basique de Microcomputer Pour la Determination des Données de Dissolution, XVII éme Semain Medical Balkanique, Istanbul, 1984, p. 327.
39. P. K. Gupta, C. T. Hung, and F. C. Lam, Drug Development and Industrial Pharmacy, 14, 1657 (1988).
40. J. A. Plaizier-Vercammen and R. E. Deneve, J. Pharm. Sci., 69, 1403 (1980).
41. P. Dufour, H. Brun, R. Chapelon, and B. Pouyet, J. Microencapsulation, 9, 465 (1992).
42. L. Öner, H. S. Kas, and A. A. Hincal, J. Microencapsulation, 5, 225 (1988).
43. C. Ahineck and J. Waltersson, Acta Pharm. Suec., 23, 139 (1986).
44. O. Alpar and V. Walters, J. Pharm. Pharmacol., 33, 419 (1981).
45. S. Benita and M. Donbrow, J. Pharm. Pharmacol., 34, 77 (1982).
46. P. B. Deasy, M. R. Brophy, B. Ecanow, and M. M. Joy, J. Pharm. Pharmacol., 32, 15 (1980).
47. L. Öner, H. S. Kaş, and A. A. Hincal, J. Microencapsulation, 5, 219 (1988).
48. R. C. Rowe, Pharmacy International, 6, 13 (1985).
49. E. Güler, M. Şumnu, Y. Yazan, and L. Öner, Drug Dev. Ind. Pharm., 15, 283, (1989).
50. M. A. El-Egokey, F. El-Khawas, A. G. Iskander, and M. M. Abdelhalek, Pharmazie, 29, 466 (1974).
51. M. Itah, M. Nakana, K. Joni, and H. Sakikawa, Chem. Pharm. Bull., 28, 1051 (1980).
52. H. S. Yalabik-Kaş, Drug Dev. Ind. Pharm., 9, 1047 (1983).
53. P. M. John, H. Minatoya, and F. J. Rosenberg, J. Pharm. Sci., 68, 475 (1979).
54. J. B. Schwartz, A. P. Simonelli, and W. I. Higuchi, J. Pharm. Sci., 57, 274 (1968).
55. N. Bergişadi and D. Gürvardar, Acta Pharmaceutica Turcica, XXXI, 161 (1989).
56. M. Gibaldi and S. Feldman, J. Pharm. Sci., 57, 787 (1968).
57. P. Singh, S. J. Desai, D. R. Flanagan, A. P. Simonelli, and W. I. Higuchi, J. Pharm. Sci., 57, 959 (1968).
58. H. Weintroub and M. Gibaldi, J. Pharm. Sci., 58, 1368 (1969).
59. S. Hugichi, H. Sasaki, Y. Shiobara, and T. Sado, Xenobiotica, 7, 469 (1977).
60. A. T. M. Serajuddin and M. Rosoff, J. Pharm. Sci., 73, 1203 (1984).
61. J. Akbuga and A. Gürsoy, S.T.P. Pharma, 3, 395 (1987).